Format

Send to

Choose Destination
Virulence. 2014 Jan 1;5(1):226-35. doi: 10.4161/viru.25991. Epub 2013 Aug 13.

A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.

Author information

1
Critical Care Department; St Luc University Hospital; Université Catholique de Louvain; Brussels, Belgium.
2
High Care Burn Unit; Military Hospital; Brussels, Belgium.
3
The Infectious Disease Division; Memorial Hospital of RI; Providence, RI USA; The Alpert Medical School of Brown University; Providence, RI USA.

Abstract

The seemingly inexorable spread of antibiotic resistance genes among microbial pathogens now threatens the long-term viability of our current antimicrobial therapy to treat severe bacterial infections such as sepsis. Antibiotic resistance is reaching a crisis situation in some bacterial pathogens where few therapeutic alternatives remain and pan-resistant strains are becoming more prevalent. Non-antibiotic therapies to treat bacterial infections are now under serious consideration and one possible option is the therapeutic use of specific phage particles that target bacterial pathogens. Bacteriophage therapy has essentially been re-discovered by modern medicine after widespread use of phage therapy in the pre-antibiotic era lost favor, at least in Western countries, after the introduction of antibiotics. We review the current therapeutic rationale and clinical experience with phage therapy as a treatment for invasive bacterial infection as novel alternative to antimicrobial chemotherapy.

KEYWORDS:

bacteriophage therapy; multidrug resistant pathogens; phage therapy; sepsis; septic shock

PMID:
23973944
PMCID:
PMC3916379
DOI:
10.4161/viru.25991
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center